These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 8609163)

  • 1. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.
    Sevinsky JR; Rao LV; Ruf W
    J Cell Biol; 1996 Apr; 133(2):293-304. PubMed ID: 8609163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor.
    Ott I; Miyagi Y; Miyazaki K; Heeb MJ; Mueller BM; Rao LV; Ruf W
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):874-82. PubMed ID: 10712416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium.
    Lupu C; Goodwin CA; Westmuckett AD; Emeis JJ; Scully MF; Kakkar VV; Lupu F
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2964-74. PubMed ID: 9409283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A; Ruf W; Rao LV
    Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor.
    Maroney SA; Ellery PE; Wood JP; Ferrel JP; Bonesho CE; Mast AE
    Biochem J; 2012 Apr; 443(1):259-66. PubMed ID: 22239091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
    Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
    J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of leukocyte elastase on tissue factor pathway inhibitor.
    Higuchi DA; Wun TC; Likert KM; Broze GJ
    Blood; 1992 Apr; 79(7):1712-9. PubMed ID: 1558967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of tissue factor-factor VIIa signaling by lipid rafts and caveolae.
    Awasthi V; Mandal SK; Papanna V; Rao LV; Pendurthi UR
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1447-55. PubMed ID: 17413039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of tissue factor pathway inhibitor to lipid rafts is not required for inhibition of factor VIIa/tissue factor activity.
    Dietzen DJ; Jack GG; Page KL; Tetzloff TA; Hall CL; Mast AE
    Thromb Haemost; 2003 Jan; 89(1):65-73. PubMed ID: 12540955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
    Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
    J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-1 enhances tissue factor pathway inhibitor exposure and function on the cell surface.
    Lupu C; Hu X; Lupu F
    J Biol Chem; 2005 Jun; 280(23):22308-17. PubMed ID: 15817451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI.
    Henriquez S; Calderon C; Quezada M; Oliva B; Bravo ML; Aranda E; Kato S; Cuello MA; Gutiérrez J; Quest AF; Owen GI
    J Cell Physiol; 2011 Dec; 226(12):3278-85. PubMed ID: 21344386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors.
    Kopp CW; Siegel JB; Hancock WW; Anrather J; Winkler H; Geczy CL; Kaczmarek E; Bach FH; Robson SC
    Transplantation; 1997 Mar; 63(5):749-58. PubMed ID: 9075849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor pathway.
    McVey JH
    Baillieres Clin Haematol; 1994 Sep; 7(3):469-84. PubMed ID: 7841596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor.
    Johnson K; Zaror I; Bauer D; Choi Y; Creasey A; Innis M
    Thromb Haemost; 1998 Oct; 80(4):585-7. PubMed ID: 9798974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity.
    Rao LV; Nordfang O; Hoang AD; Pendurthi UR
    Blood; 1995 Jan; 85(1):121-9. PubMed ID: 7803789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat.
    Han X; Girard TJ; Baum P; Abendschein DR; Broze GJ
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2563-7. PubMed ID: 10521388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probable regulation of factor VIIa-tissue factor and prothrombinase by factor Xa-TFPI and TFPI in vivo.
    Gouin-Thibault I; Dewar L; Craven S; Kulczycky M; Wun TC; Ofosu FA
    Br J Haematol; 1996 Dec; 95(4):738-46. PubMed ID: 8982054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein.
    Hamik A; Setiadi H; Bu G; McEver RP; Morrissey JH
    J Biol Chem; 1999 Feb; 274(8):4962-9. PubMed ID: 9988740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.